Ronald Scheff
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 10%
- Genetics top 5%
- Molecular Biology
- Radiology, Nuclear Medicine and Imaging top 10%
- Co-authors
- Bryan J. SchneiderPaul J. ChristosSusan C. PannulloJohn A. BoockvarAshish SaxenaHoward A. RiinaSherese FralinJared Knopman
- Topics
- Glioma Diagnosis and Treatment (8 papers)Lung Cancer Treatments and Mutations (8 papers)Cancer Immunotherapy and Biomarkers (5 papers)
- Partner nations
- United StatesFranceSpain
In The Last Decade
Ronald Scheff
24 papers receiving 866 citations
Hit Papers
Peers
Comparison fields: 5 of 89
- Oncology 519
- Pulmonary and Respiratory Medicine 336
- Genetics 166
- Molecular Biology 161
- Radiology, Nuclear Medicine and Imaging 138
Countries citing papers authored by Ronald Scheff
This map shows the geographic impact of Ronald Scheff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald Scheff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald Scheff more than expected).
Fields of papers citing papers by Ronald Scheff
This network shows the impact of papers produced by Ronald Scheff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald Scheff. The network helps show where Ronald Scheff may publish in the future.
Co-authorship network of co-authors of Ronald Scheff
This figure shows the co-authorship network connecting the top 25 collaborators of Ronald Scheff. A scholar is included among the top collaborators of Ronald Scheff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald Scheff. Ronald Scheff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 16 | |
| 3 | Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trialbreakdown → | 210 |
| 4 | 0 | |
| 5 | 14 | |
| 6 | 8 | |
| 7 | 1 | |
| 8 | 139 | |
| 9 | 10 | |
| 10 | 7 | |
| 11 | 27 | |
| 12 | 56 | |
| 13 | 1 | |
| 14 | 71 | |
| 15 | Phase I/II study of oral erlotinib for treatment of relapsed/refractory glioblastoma multiforme and anaplastic astrocytoma. | 20 |
| 16 | 55 | |
| 17 | 123 | |
| 18 | Superselective intraarterial cerebral infusion of bevacizumab: a revival of interventional neuro-oncology for malignant glioma. | 39 |
| 19 | 9 | |
| 20 | 45 |
About Ronald Scheff
Ronald Scheff is a scholar working on Genetics, Oncology and Pulmonary and Respiratory Medicine, having authored 26 papers that have together received 880 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (8 papers), Lung Cancer Treatments and Mutations (8 papers) and Cancer Immunotherapy and Biomarkers (5 papers). The work is most often cited by research in Oncology (519 citations), Genetics (166 citations) and Pulmonary and Respiratory Medicine (336 citations). Ronald Scheff has collaborated with scholars based in United States, France and Spain. Frequent co-authors include Bryan J. Schneider, Paul J. Christos, Susan C. Pannullo, John A. Boockvar, Ashish Saxena, Howard A. Riina, Sherese Fralin, Jared Knopman, Benjamin E. Lee and Jeffrey L. Port. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.